-
Breaking Down Neurocrine Biosciences: 12 Analysts Share Their Views
05 Sep 2025 13:51 GMT
… Neurocrine Biosciences analyst ratings.
All You Need to Know About Neurocrine Biosciences
Neurocrine Biosciences … endometriosis; and Oriahnn capsules to treat uterine fibroids.
Understanding the Numbers: Neurocrine Biosciences … Neurocrine Biosciences …
-
The Analyst Verdict: Neurocrine Biosciences In The Eyes Of 17 Experts
31 Jul 2025 20:34 GMT
… on Neurocrine Biosciences analyst ratings.
Get to Know Neurocrine Biosciences Better
Neurocrine Biosciences … hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules … capacity.
Revenue Growth: Neurocrine Biosciences's remarkable performance …
-
Neurocrine Biosciences Grows Pipeline While Maintaining Steady Investor Confidence
28 Jul 2025 19:41 GMT
… raising the price target. Neurocrine Biosciences Grows Pipeline While Maintaining Steady … patient with a neurological disorder. Neurocrine Biosciences, Inc. (NASDAQ:NBIX) develops … ’s chorea, adrenal hyperplasia, endometriosis, and uterine fibroids. The …
-
Neurocrine Biosciences Presents New Data Showing Significant Patient-Reported Improvements in Health-Related Quality of Life with INGREZZA® (valbenazine) Capsules in Older Adults with Tardive Dyskinesia
20 Jun 2025 12:46 GMT
…
INGREZZA, developed by Neurocrine Biosciences, selectively inhibits VMAT2 with … Medication Guide.
About Neurocrine Biosciences, Inc.
Neurocrine Biosciences is a leading … classic congenital adrenal hyperplasia, endometriosis* and uterine fibroids,* …
-
Neurocrine Biosciences Appoints Lewis Choi As Chief Information Officer
09 Jun 2025 21:32 GMT
… University of California, Berkeley.
About Neurocrine Biosciences
Neurocrine Biosciences is a leading neuroscience-focused … disease, classic congenital adrenal hyperplasia, endometriosis* and uterine fibroids*, as well …
-
Analyst Expectations For Neurocrine Biosciences's Future
02 Jun 2025 21:08 GMT
… recent developments related to Neurocrine Biosciences. This information offers … on Neurocrine Biosciences analyst ratings.
Discovering Neurocrine Biosciences: A Closer Look
Neurocrine Biosciences … ; Orilissa tablets for endometriosis; and Oriahnn capsules …
-
Neurocrine Biosciences Presents New Positive Data from Phase 2 Study of NBI-1117568 in Adults with Schizophrenia at American Society of Clinical Psychopharmacology 2025
28 May 2025 20:30 GMT
… visit ClinicalTrials.gov.
About Neurocrine Biosciences' Muscarinic Portfolio
In … health impacts.
About Neurocrine Biosciences, Inc.
Neurocrine Biosciences is a leading … classic congenital adrenal hyperplasia, endometriosis* and uterine fibroids,* as …
-
Neurocrine Biosciences To Present Wide-Ranging One-Year Data From Phase 3 Cahtalysttm Pediatric Study At Pediatric Endocrine Society 2025 Annual Meeting
16 May 2025 14:34 GMT
… Prescribing Information .
About Neurocrine Biosciences, Inc.
Neurocrine Biosciences is a leading … classic congenital adrenal hyperplasia, endometriosis* and uterine fibroids,* as … are registered trademarks of Neurocrine Biosciences, Inc. CRENESSITY, CAHtalyst …
-
Neurocrine Biosciences Presents Data Adding To The Growing Body Of Evidence Demonstrating Functional And Quality Of Life Improvements In Patients With Tardive Dyskinesia
16 May 2025 13:24 GMT
…
INGREZZA, developed by Neurocrine Biosciences, selectively inhibits VMAT2 with … Guide .
About Neurocrine Biosciences, Inc.
Neurocrine Biosciences is a leading neuroscience … classic congenital adrenal hyperplasia, endometriosis* and uterine fibroids,* …
-
Neurocrine Biosciences to Present at Upcoming Investor Conferences in May
06 May 2025 20:10 GMT
… approximately one month.
About Neurocrine Biosciences
Neurocrine Biosciences is a leading neuroscience … classic congenital adrenal hyperplasia, endometriosis* and uterine fibroids*, as … collaboration with AbbVie)
The NEUROCRINE BIOSCIENCES Logo Lockup and YOU …
About
© 1995-2025